Greater Cannabis Company (GCAN) Total Current Liabilities (2016 - 2026)
Greater Cannabis Company (GCAN) recorded quarterly Total Current Liabilities of $776464.0 in Q1 2026, up 4.58% quarter-over-quarter from $742464.0 in Q4 2025, and down 23.05% on a YoY basis from $1.0 million in Q1 2025.
Greater Cannabis Company (GCAN) Total Current Liabilities (2016 - 2026) Analysis & Trends
Greater Cannabis Company's Total Current Liabilities history runs 11 years deep, the most recent figure standing at $776464.0 for Q1 2026.
- In Q1 2026, Total Current Liabilities fell 23.05% year-over-year to $776464.0; the TTM figure through Mar 2026 stood at $776464.0 (down 23.05% YoY), while the FY2025 annual figure was $742464.0, down 17.33% from the prior year.
- Total Current Liabilities was $776464.0 for Q1 2026 at Greater Cannabis Company, up from $742464.0 in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $1.1 million in Q3 2025 to a low of $742464.0 in Q4 2025.
- Historically, Total Current Liabilities has averaged $897704.7 across 5 years, with a median of $860874.0 in 2024.
- The sharpest annual moves came in 2022 and 2026: Total Current Liabilities jumped 44.13% in 2022, then decreased 23.05% in 2026.
- A 5-year view of Total Current Liabilities shows it stood at $825277.0 in 2022, then advanced by 1.0% to $833508.0 in 2023, then advanced by 7.74% to $898058.0 in 2024, then dropped by 17.33% to $742464.0 in 2025, then increased by 4.58% to $776464.0 in 2026.
- The last three Total Current Liabilities figures came in at $776464.0 (Q1 2026), $742464.0 (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 333.17 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 618.78 Mn |
| 10 | Greater Cannabis Company | - | - | - | 776,464.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 776,464.00 |
| Dec 31, 2025 | 742,464.00 |
| Sep 30, 2025 | 1.13 Mn |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 1.01 Mn |
| Dec 31, 2024 | 898,058.00 |
| Sep 30, 2024 | 860,874.00 |
| Jun 30, 2024 | 833,993.00 |
| Mar 31, 2024 | 839,333.00 |
| Dec 31, 2023 | 833,508.00 |
| Sep 30, 2023 | 856,570.00 |
| Jun 30, 2023 | 881,605.00 |
| Mar 31, 2023 | 848,618.00 |
| Dec 31, 2022 | 825,277.00 |
| Sep 30, 2022 | 862,190.00 |
| Jun 30, 2022 | 965,767.00 |
| Mar 31, 2022 | 998,504.00 |
| Dec 31, 2021 | 861,999.00 |
| Sep 30, 2021 | 782,506.00 |
| Jun 30, 2021 | 670,049.00 |